window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 19, 2025

  • News
  • About Us
Contact Us

Oncology

  • Cell & Gene Therapy,Oncology,Orphan drugs,Regulatory Affairs

    Minovia Therapeutics gains FDA orphan drug designation for MNV-201 in myelodysplastic syndrome

    Minovia Therapeutics has received orphan drug designation from the US [...]

    October 17, 2025
  • Biologics & Biosimilars,Biotech,Chronic diseases,Clinical Development,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Enterome’s EO2463 receives FDA fast track designation for follicular lymphoma watch-and-wait treatment

    Enterome has received Fast Track designation from the US Food [...]

    October 17, 2025
  • Clinical studies,Clinical Trials,Oncology,Regulatory Affairs

    MaaT Pharma’s Phase 2b Phoebus trial cleared to continue after positive safety review

    MaaT Pharma has reported a positive outcome from the second [...]

    October 8, 2025
  • Biotech,Clinical studies,Oncology,Pharmaceuticals and therapeutics

    Kairos Pharma to present Phase 2 prostate cancer data at ESMO 2025

    Kairos Pharma, Ltd. will present positive safety and early efficacy [...]

    October 8, 2025
  • Biotech,Oncology,Regulatory Affairs

    Orca Bio’s Orca-T receives FDA Priority Review for blood cancer treatment

    The US Food and Drug Administration (FDA) has accepted for [...]

    October 7, 2025
  • Clinical Development,Clinical studies,Clinical Trials,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy

    CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

    October 7, 2025
  • Biotech,Oncology,Partnerships & Funding,Research & Development

    Myricx Bio appoints Boston-based Mohit Rawat as CEO and expands team in US and UK

    Myricx Bio has appointed Boston-based Mohit Rawat as chief executive [...]

    October 6, 2025
  • CDMOs & Manufacturing,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    XenoSTART and Minerva Imaging expand collaboration on radiopharmaceutical drug development

    XenoSTART and Minerva Imaging have expanded their long-standing partnership to [...]

    October 2, 2025
  • Artificial Intelligence,Clinical studies,Digital Health,Global health,Oncology,Partnerships & Funding,Women's Health

    SpotitEarly and Hackensack Meridian Health partner to advance early detection with trained dogs

    SpotitEarly, a US-based early cancer detection startup, has announced a [...]

    October 1, 2025
  • Biomanufacturing,Clinical Development,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Crown Bioscience opens new model development center in North Carolina to expand US oncology research

    Crown Bioscience has opened a model development center in Kannapolis, [...]

    September 29, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaxCyte signs platform licence with Moonlight Bio to advance T cell therapies for solid tumours
    Categories: Biotech, Cell & Gene Therapy, Partnerships & Funding, Research & Development
  • Nordic Life Science Days 2025 opens in Gothenburg with calls for deeper collaboration and global investment
    Categories: European biotech, Events and Conferences, Global health, Healthcare leadership, Market Access & Commercialization, Partnerships & Funding, Research & Development
  • New AI tool offers real-time insights into clinical trial participant behavior
    Categories: Artificial Intelligence, Clinical Development, Digital Health, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top